Nita Tobuhiro, Baba Hironori, Hironaka Yuji, Shinohara Gen, Ochiai Yoshie, Tokunaga Shigehiko
Department of Cardiovascular Surgery, JCHO Kyushu Hospital, Kitakyushu, Fukuoka, Japan.
Ann Vasc Dis. 2025;18(1). doi: 10.3400/avd.cr.25-00016. Epub 2025 Jun 5.
Late postoperative type 3 endoleaks associated with the AFX (Endologix, Irvine, CA, USA) stent-graft are commonly reported. The AFX's endoskeletal design raises concerns about wire entrapment between its frame and fabric, as well as a risk of type 1a endoleak. An 84-year-old man with prior EVAR using the AFX presented with a type 3b endoleak 4 years postoperatively. He underwent relining with the TREO stent-graft (Terumo Aortic, Sunrise, FL, USA), which enabled easy contralateral gate cannulation and secured a long proximal landing zone. The TREO appears to be a viable option for relining the AFX in type 3b endoleak cases.
术后晚期与AFX(美国加利福尼亚州欧文市Endologix公司)覆膜支架相关的3型内漏较为常见。AFX的内骨骼设计引发了对其框架与织物之间钢丝卡压的担忧,以及1a型内漏的风险。一名曾使用AFX进行过腔内腹主动脉瘤修复术(EVAR)的84岁男性在术后4年出现了3b型内漏。他接受了TREO覆膜支架(美国佛罗里达州森赖斯市泰尔茂主动脉公司)重置,这使得对侧入路插管变得容易,并确保了较长的近端锚定区。对于3b型内漏病例中AFX的重置,TREO似乎是一个可行的选择。